Trial Details
COMPLETEDBasic Information
| Clinical ID | c53 |
|---|---|
| Identifier | NCT02825914 |
| Trial Title | CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative|Inflammatory Bowel Diseases |
| Interventions | DIETARY_SUPPLEMENT: Casein glycomacropeptide (CGMP)|DIETARY_SUPPLEMENT: Placebo |
Participant Information
| Sponsor | University of Aarhus |
|---|---|
| City | Aarhus C |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2016-09-01 |
|---|---|
| Primary Completion Date | 2019-07-01 |
| Completion Date | 2019-10-01 |